BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34988480)

  • 1. Cardiovascular Burden and Adverse Events in Patients With Esophageal Cancer Treated With Chemoradiation for Curative Intent.
    Søndergaard MMA; Nordsmark M; Nielsen KM; Poulsen SH
    JACC CardioOncol; 2021 Dec; 3(5):711-721. PubMed ID: 34988480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction in myocardial function and oxygen consumption after chemoradiotherapy in patients with esophageal cancer.
    Astrup Søndergaard MM; Nordsmark M; Sloth Møller D; Melgaard Nielsen K; Poulsen SH
    Acta Oncol; 2022 May; 61(5):566-574. PubMed ID: 35289694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global left ventricular longitudinal systolic strain as a major predictor of cardiovascular events in patients with atrial fibrillation.
    Su HM; Lin TH; Hsu PC; Lee WH; Chu CY; Lee CS; Voon WC; Lai WT; Sheu SH
    Heart; 2013 Nov; 99(21):1588-96. PubMed ID: 24014280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ratio of Early Mitral Inflow Velocity to the Global Diastolic Strain Rate and Global Left Ventricular Longitudinal Systolic Strain Predict Overall Mortality and Major Adverse Cardiovascular Events in Hemodialysis Patients.
    Huang JC; Su HM; Wu PY; Lee JJ; Lee WH; Chen SC; Chiu YW; Hsu YL; Chang JM; Chen HC
    Dis Markers; 2019; 2019():7512805. PubMed ID: 31583030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental prognostic value of assessing left ventricular myocardial mechanics in patients with chronic systolic heart failure.
    Motoki H; Borowski AG; Shrestha K; Troughton RW; Tang WH; Thomas JD; Klein AL
    J Am Coll Cardiol; 2012 Nov; 60(20):2074-81. PubMed ID: 23083779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac Adverse Events in
    Kunimasa K; Kamada R; Oka T; Oboshi M; Kimura M; Inoue T; Tamiya M; Nishikawa T; Yasui T; Shioyama W; Nishino K; Imamura F; Kumagai T; Fujita M
    JACC CardioOncol; 2020 Mar; 2(1):1-10. PubMed ID: 34396203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Predictive value of N-terminal B-type natriuretic peptide on outcome of elderly hospitalized non-heart failure patients].
    Li YY; Liang YD; Yao SM; Zheng PP; Zeng XZ; Cui LL; Guo D; Wang H; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Aug; 48(8):661-668. PubMed ID: 32847322
    [No Abstract]   [Full Text] [Related]  

  • 9. Association between left ventricular global longitudinal strain and natriuretic peptides in outpatients with chronic systolic heart failure.
    Gaborit F; Bosselmann H; Tønder N; Iversen K; Kümler T; Kistorp C; Sölétormos G; Goetze JP; Schou M
    BMC Cardiovasc Disord; 2015 Aug; 15():92. PubMed ID: 26289429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
    Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
    J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial.
    DeVore AD; McNulty S; Alenezi F; Ersboll M; Vader JM; Oh JK; Lin G; Redfield MM; Lewis G; Semigran MJ; Anstrom KJ; Hernandez AF; Velazquez EJ
    Eur J Heart Fail; 2017 Jul; 19(7):893-900. PubMed ID: 28194841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left Ventricular Global Longitudinal Strain Is Associated With Cardiovascular Outcomes in Patients Who Underwent Permanent Pacemaker Implantation.
    Kim DY; Lkhagvasuren P; Seo J; Cho I; Hong GR; Ha JW; Shim CY
    Front Cardiovasc Med; 2021; 8():705778. PubMed ID: 34395565
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of left ventricular systolic dysfunction in pre-dialysis and dialysis patients with preserved left ventricular ejection fraction.
    Hensen LCR; Goossens K; Delgado V; Abou R; Rotmans JI; Jukema JW; Bax JJ
    Eur J Heart Fail; 2018 Mar; 20(3):560-568. PubMed ID: 29164753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natriuretic peptide plasma concentrations and risk of cardiovascular versus non-cardiovascular events in heart failure with reduced ejection fraction: Insights from the PARADIGM-HF and ATMOSPHERE trials.
    Khan MS; Kristensen SL; Vaduganathan M; Kober L; Abraham WT; Desai AS; Solomon SD; Swedberg K; Dickstein K; Zile MR; Packer M; McMurray JJ; Butler J
    Am Heart J; 2021 Jul; 237():45-53. PubMed ID: 33621540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction.
    Machino-Ohtsuka T; Seo Y; Ishizu T; Sugano A; Atsumi A; Yamamoto M; Kawamura R; Machino T; Kuroki K; Yamasaki H; Igarashi M; Sekiguchi Y; Aonuma K
    J Am Coll Cardiol; 2013 Nov; 62(20):1857-65. PubMed ID: 23916940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular adverse events and prognosis in patients with haematologic malignancies and breast cancer receiving anticancer agents: Kurume-CREO Registry insights.
    Shibata T; Nohara S; Morikawa N; Shibao K; Ito S; Shibata R; Toh U; Nagafuji K; Fukami K; Fukumoto Y
    Eur J Prev Cardiol; 2023 Dec; 30(18):1941-1949. PubMed ID: 37352112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echocardiographic parameters of left ventricular size and function as predictors of symptomatic heart failure in patients with a left ventricular ejection fraction of 50-59% treated with anthracyclines.
    Mousavi N; Tan TC; Ali M; Halpern EF; Wang L; Scherrer-Crosbie M
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):977-84. PubMed ID: 25925220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left Ventricular Systolic Function in Long-Term Survivors of Allogeneic Hematopoietic Stem Cell Transplantation.
    Massey RJ; Diep PP; Ruud E; Burman MM; Kvaslerud AB; Brinch L; Aakhus S; Gullestad LL; Beitnes JO
    JACC CardioOncol; 2020 Sep; 2(3):460-471. PubMed ID: 34396253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular asymmetric remodeling and subclinical left ventricular dysfunction in patients with calcific aortic valve stenosis - Results from a subanalysis of the PROGRESSA study.
    Bernard J; Tastet L; Capoulade R; Shen M; Clisson M; Guzzetti E; Larose É; Arsenault M; Bédard É; Côté N; Clavel MA; Pibarot P
    Int J Cardiol; 2021 Jun; 332():148-156. PubMed ID: 33727121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.